title: Interstitial pneumonitis induced by bicalutamide and leuprorelin acetate for prostate cancer.
abstract: Maximal androgen blockade therapy is the standard endocrine treatment for advanced prostate cancer. We report here an unusual case of interstitial pneumonitis induced by bicalutamide and/or leuprorelin acetate treatment for metastatic prostate cancer.
authors: Department of Urology, Yokosuka Hokubu Kyosai Hospital, Funakoshi, Yokosuka, Kanagawa, Japan.
authors: Koichi
authors: K
authors: Shioi
authors: Minoru
authors: M
authors: Yoshida
authors: Naoki
authors: N
authors: Sakai
mesh_terms: D000368:Aged; D000813:Anilides / Q000008:administration & dosage; D000971:Antineoplastic Combined Chemotherapy Protocols / Q000009:adverse effects*; D005500:Follow-Up Studies; D005938:Glucocorticoids / Q000008:administration & dosage; D006801:Humans; D016729:Leuprolide / Q000008:administration & dosage; D017563:Lung Diseases, Interstitial / Q000139:chemically induced* / Q000175:diagnosis / Q000188:drug therapy; D008297:Male; D008776:Methylprednisolone Hemisuccinate / Q000008:administration & dosage; D009570:Nitriles; D011471:Prostatic Neoplasms / Q000188:drug therapy*; D014105:Tosyl Compounds; D016896:Treatment Outcome
chemical_list: D000813:Anilides; D005938:Glucocorticoids; D009570:Nitriles; D014105:Tosyl Compounds; D008776:Methylprednisolone Hemisuccinate; C053541:bicalutamide; D016729:Leuprolide